Wire-based fractional flow reserve (FFR) is a diagnostic tool used to evaluate the ischemic burden of coronary lesions. Large-scale studies have shown that FFR-guided revascularization is associated with better clinical outcomes. However, wide adoption of this technology is limited due to the considerable cost, additional time needed for set-up and performance of the measurement as well as the invasiveness of the procedure which requires pressure wire placement across the lesion into the distal segment of the coronary artery. To overcome these limitations new, promising, and less-/non-invasive methods were developed. These methods are based on computational fluid dynamics analysis and three-dimensional lumen reconstruction. The aim of this paper is to review scientific evidence supporting the clinical safety and efficacy of these techniques, such as instantaneous wave-free ratio, quantitative flow ratio and FFR calculated from computed tomographic angiography. 
Introduction
Coronary artery disease (CAD) is one of the main causes of morbidity and mortality in developed countries [1, 2] . Coronary angiography remains the gold standard for the diagnosis of CAD, however, its ability to differentiate ischemic from non-ischemic lesions is limited. In this respect, fractional flow reserve (FFR), which takes into consideration the functional severity of coronary stenosis, outperforms the traditional diagnostic approach, based solely on morphometric assessment [3, 4] . Unfortunately, the adoption of FFR in everyday clinical practice is slow and is utilized in only a minority of centers [5, 6] . Härle et al. [7] found that FFR was used in 3.2% of all diagnostic procedures performed in Germany. In Poland penetration rate of FFR was even lower and did not exceed 2% in 2014 [8] . The main limiting factors include: 1) considerable time need for set-up and conduction of the examination; 2) high cost of diagnostic probe and adenosine infusion; 3) invasiveness, as it requires insertion of a pressure wire across the lesion into the distal part of the vessel, which is associated with increased risk of serious complications, e.g. ventricular arrhythmias and coronary vessel dissection (occurring in 0.5% of procedures), and 4) patient-related contraindications (hypotension, asthma, second-degree atrioventricular blocks) [9] [10] [11] . To overcome these limitations, less invasive techniques based on computational fluid dynamics (CFD) and threedimensional (3D) lumen reconstruction have been proposed [12] [13] [14] [15] [16] .
Pressure wire methods

Instantaneous wave-free ratio
Instantaneous wave-free ratio (iFR) is one alternative method that does not require adenosine infusion (Fig. 1) . Although vessel wiring is still necessary, iFR measurements are quicker to perform and are cheaper than FFR. The scientific basis came from findings by Sen et al. [17] who demonstrated that functional assessment of coronary lesions comparable to FFR is possible without drug induced hyperemia, during the so-called "wave-free period". This period is seen in diastole and characterized by minimal and stable coronary resistance (similar to "hyperemic-like" conditions), which makes the corresponding trans-stenotic pressure gradient to flow directly and lessen lesion severity [17] .
The first published clinical study evaluating the correlation between iFR and FFR (ADenosine Vasodilator Independent Stenosis Evaluation [ADVISE]) demonstrated a close
correlation between values obtained with these two methods (r = 0.9; p < 0.001) [17] . The possibility of iFR real-time measurement was proven by ADVISE, an in-practice study. The authors assessed 392 angiographically intermediate lesions and demonstrated that the best cutoff value of iFR corresponding to FFR ≤ 0.80 was an iFR ≤ 0.90 and resulted in classification agreement in 80% of cases, specificity of 79%, sensitivity of 81%, positive predictive value (PPV) of 71% and negative predictive value (NPV) of 87% [18] . What is more, it was shown that iFR correlates more closely than FFR with coronary flow velocity reserve, which suggests that iFR may be a more physiological parameter of disease severity [19] .
In 2017, two pivotal trials evaluating iFR in clinical practice were published. The Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularization (DEFINE-FLAIR) trial consisting of almost 2500 patients with stable CAD, proved that iFR-guided is noninferior to FFR-guided coronary revascularization with respect to composite risk of death from any cause, nonfatal myocardial infarction (MI) or unplanned revascularization during 1-year follow-up. Additionally, study results showed that in iFR group median procedural time was significantly shorter (40.5 vs. 45 min; p = 0.001; iFR vs. FFR, respectively) and fewer patients had adverse procedural symptoms (3.1% vs. 30.8%; p < 0.001; iFR vs. FFR, respectively) [20] . The Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome (iFR-SWEDE-HEART) trial consisting of over 2000 patients with stable CAD or acute coronary syndrome (17.5% patients) showed similar results. The primary composite end-point (defined as composite of death from any cause, nonfatal MI or unplanned revascularization) occurred in 6.7% of the patients in the iFR group and in 6.1% of the patients in the FFR group in 1-year follow-up (p = 0.007 for noninferiority). Authors, just as in the previously described study, reported that chest discomfort occurred less often during the iFR-guided procedure (3.0% vs. 68.3%; p < 0.001) [21] . Results of these two trials were reflected in European and in American guidelines, in which iFR was regarded as equivalent to FFR in hemodynamic assessment of intermediate-grade stenosis [22, 23] .
Alternative pressure wire methods
Over the years other adenosine-free methods based on assessment of diastolic resting indices have been proposed. Recently published data proved a high correlation between iFR and resting distal coronary to aortic pressure (Pd/Pa). Both were associated with lesion anatomic and hemodynamic severity, showing excellent agreement between them [24, 25] . It seems that the adoption of Pd/Pa could be easier, in comparison to iFR, it was analyzable in a significantly higher number of cases [25] . Other diastolic resting indexes included resting Pd/Pa during the complete duration of diastole, in 25% to 75% of diastole, at midpoint of diastole (Fig. 2 ). All the above-mentioned parameters were proven to be identical to iFR, not only numerically, but also with respect to their agreement to FFR [26] . Though, they are all very promising, further studies are needed to evaluate their clinical value.
Computational-based methods
Quantitative flow ratio
In 2013 Morris et al. [13] published results from the VIRTUal FFR From Coronary Angiography (VIRTU-1) study, designed to demonstrate the feasibility of FFR computations based solely on two-dimensional coronary angiography images (virtual FFR [vFFR] ). The study population consisted of 19 patients. Compared to FFR, vFFR had an accuracy of 97%, sensitivity of 86%, specificity of 100%, PPV of 100% and NPV of 97%. Although, there was a strong correlation between vFFR and wire-based FFR (r = 0.84), the image analysis was labor-and time-consuming, requiring 24 h to process the above-mentioned data. Of note, authors used a "one-size fits all" approach, which assumed constant coronary vessel resistance. Such an assumption carries the risk of stenosis misclassification due to possible changes in downstream microcirculatory resistance [13] .
Papafakis et al. [27] The method was compared to FFR in 120 patients showing accuracy of 88%, sensitivity of 90% and specificity of 86% for the optimal vFAI cut-off point (≤ 0.82). Additionally, the vFAI was superior to 3D QCA in predicting hemodynamic significance of coronary stenosis and demonstrated close correlation and good agreement with wire-based FFR values. The main limitation of vFAI, which is based solely on lesion geometry, is the fact that it does not take into account microvascular resistance and size of myocardial territory subtended by the vessel [27] .
To overcome these limitations, the computed FFR (FFRQCA) based on mean volumetric flow rate at hyperemia derived from 3D vessel invasive coronary angiography (ICA) reconstruction, Thrombolysis in Myocardial Infarction (TIMI) frame count and CFD utilization was proposed (Fig. 3 ). The analysis of 77 vessels provided an 88% overall accuracy of FFRQCA for diagnosis of ischemia (defined as FFR ≤ 0.8). There was a strong correlation between FFRQCA and FFR values (r = 0.81, p < 0.001) with a mean difference of ± 0.06 (p = 0.054) [12] .
One of the main advantages of this method is short computation time, which did not exceed 10 min in total processing. Additionally, this method provides an evaluation of the entire coronary tree, whereas in wire-based FFR, only those lesions in which a pressure wire is inserted can be assessed [28] . A recently published study demonstrated retrospectively analyzed results of 306 intermediate lesions, which had been previously evaluated using FFR. In contradiction to previous studies, which utilized core-lab assessment, in this particular study used an on-site QFR calculation in all cases. It showed that the Pearson correlation was strong for QFR (r = 0.85). Additionally, optimal QFR decision value of 0.79 was identified, this corresponded to FFR = 0.80 (AUC = 0.94). After introduction of the cut-off value of ≤ 0.74 and > 0.83, an excellent diagnostic performance of QFR was achieved, with sensitivity and specificity > 95%. Additionally, it was confirmed that the time for QFR analysis was relatively short and substantially decreased with the number of analyzed cases. The first 50 QFR analysis took an average of 5 min 59 s, whereas in the final 50 cases the mean time was 2 min 7 s [31] .
Westra et al. [32] prospectively evaluated QFR in 240 lesions and correctly classified 83% of the lesions when an FFR cut off value of 0.8 was used. They also achieved a sensitivity of 77%, specificity of 86%, PPV of 87% and NPV of 75%.
In 2018 the results from The FAVOR II Europe-Japan Study were published. In this international, multicenter trial 329 patients were enrolled. QFR values were calculated online in catherization laboratories during the procedure. Sensitivity and specificity were > 86% for QFR, which was significantly higher than for 2-dimensional QCA (sensitivity 44.2%; p < 0.001 and specificity 76.5%; p = 0.002) [33] .
The most recently published study demonstrated that QFR may also be utilized in acute coronary syndrome settings, particularly in guiding non-culprit lesion revascularization in patients presenting with ST-segment elevation MI [34] . Additionally, the QFR good intercore laboratory reproducibility had already been proven [35] .
Although QFR is a very promising method, there are some technical limitations that should be taken into account. At present, the degree of flow-limiting stenosis of the ostial left main and ostial right coronary artery lesions cannot be reliably measured. Supraventricular tachyarrhythmia leading to an altered filling pattern of coronary arteries remains an exclusion criterion for FFRQCA calculation. Additionally, patients with coronary artery bypass grafting supplying evaluated vessels or with collateral circulation have not been adequately studied [12] . Last, the timing of contrast injection may also affect the FFRQCA values.
Additionally, data on clinical outcomes i.e. patient quality of life and costeffectiveness remains lacking. This gap may will hopefully be addressed by the upcoming FAVOR III trial, which is designed as a prospective, randomized, multicenter clinical outcome study. With a planned enrollment of approximately 2000 patients, it is powered to establish the role of this method in the diagnostic process of CAD patients.
Computed tomographic angiography
Computed tomographic angiography (CTA) of the coronary vessels was the first noninvasive diagnostic imaging method providing data for CFD analysis to derive FFRequivalent measurements (Fig. 4) . Koo et al. [14] Authors concluded that the addition of FFRCT to standard coronary CTA measurements might enhance diagnostic accuracy and this method's utility [14] .
Min et al. [15] studied 252 stable patients who underwent coronary CTA, QCA and FFR measurements. Patients with a history of coronary artery bypass grafting or with suspected in-stent restenosis on the basis of CT were excluded. The FFRCT calculation was also based on coronary CTA. One analysis took up to 6 hours. Authors reported FFRCT's accuracy of 73%, sensitivity of 90%, specificity of 54%, PPV of 67%, and NPV of 84% for diagnosis of ischemia-inducing lesions on a per-patient basis. The study did not achieve its pre-specified level of per-patient diagnostic accuracy, however, it showed that adding FFRCT analysis to plain CTA assessment improved diagnostic accuracy. Authors emphasized that FFRCT had high negative predictive value and high sensitivity, indicating that coronary angiogram is not needed when FFRCT's results are normal, despite significant stenosis in CTA [15] .
A refined version of FFRCT calculation was evaluated by Nørgaard et al. [16] who studied 254 patients with coronary CTA, QCA and FFR measurements. The new approach was significantly quicker with a mean time to results of less than 4 h (depending on CT scan quality and CAD burden). On a per-vessel basis, authors found diagnostic an accuracy of 86%, sensitivity of 84%, specificity of 86%, PPV of 61%, and NPV of 95% for FFRCT under 0.8, which correlated well with FFR values under 0.8. They concluded that FFRCT has high diagnostic performance compared with standard FFR measurements [16] . and CTA/FFRCT testing. In the usual care arm, significantly more patients who underwent coronary angiography had no obstructive CAD when compared to CTA/FFRCT care arm (73.3% vs. 12.4%; p < 0.0001). This observation was further confirmed in a propensity score matching analysis of 148 pairs (72% vs. 12%; p < 0.0001). Most importantly there were no major adverse cardiac events over the 90-day follow-up period for any patient in whom ICA was canceled based on negative results of the CTA/FFRCT [36] .
Further confirmation of FFRCT diagnostic value comes from a recently published cohort of almost 700 patients, who underwent FFRCT evaluation. The composite endpoint included all-cause death, MI, hospitalization for unstable angina, and unplanned revascularization. Patients were divided into four groups: (1) patients with coronary stenosis < 30% in CTA, who received optimal medical treatment (OMT); (2) patients with FFRCT > 0.8, who also received OMT; (3) patients with FFRCT ≤ 0.80, who did not undergo any further testing and received OMT; (4) patients with FFRCT ≤ 0.80, who on the top of OMT were referred to ICA. Risk of MI was higher in group 3 than in group 4 (8% vs. 1.3%; p < 0.001), indicating that FFRCT is an effective diagnostic tool to differentiate patients with intermediate coronary lesions who may benefit from invasive treatment [37] .
In conclusion, the CTA/FFRCT analysis is a safe diagnostic method characterized however, by moderate diagnostic value. In patients already scheduled for CTA, adding FFRCT does not require additional imaging, radiation or medication [14] [15] [16] . Limitations of this method include long post-processing time, precluding online analysis and high cost.
Additionally, the CTA dataset must be sent to a core laboratory to calculate FFR values. This is expensive and time-consuming. What is more, FFRCT is feasible only in CTA eligible patients, precluding a significant share of the CAD population, such as patients with massive calcifications, atrial fibrillation, previous stent implantation and others [38] . Moreover, vessel size may affect FFRCT values as well. Recently Gaur et al. [39] proved that volume-to-mass ratio, defined as total coronary vessel lumen volume relative to left ventricular mass, has a statistically significant influence on FFRCT's accuracy and specificity. (Table 1 ). Advantages and disadvantages of above-mentioned diagnostic tools are summed up in Table 2 .
Conclusions
It is thought herein, that all these methods will find their place in the management of patients with CAD. It seems that QFR and FFRCT should be perceived as more complementary, rather than competitive modalities. While FFRCT may lead to better identification of patients who would not benefit from ICA investigation, QFR may be used on-line to assess the hemodynamic significance of a lesion during ICA and eliminate risks associated with wiring of a coronary artery. It is essential to utilize cut-off values in which QFR has excellent agreement with FFR measurements ("grey-zone" concept). If results of the upcoming clinical validation will be positive, one may foresee a change in the current diagnostic algorithm by incorporating alternative methods for functional assessment of intermediate coronary lesions (Fig. 5) . 
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